Gerk PM - Search Results

1

The Caco-2 Model: Modifications and enhancements to improve efficiency and predictive performance.

Panse N, Gerk PM. Panse N, et al. Among authors: gerk pm. Int J Pharm. 2022 Aug 25;624:122004. doi: 10.1016/j.ijpharm.2022.122004. Epub 2022 Jul 9. Int J Pharm. 2022. PMID: 35820514 Review.

2

Quantitative Determination of (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate (Ketone Ester) and Its Metabolites Beta-hydroxybutyrate, 1-3-Butanediol, and Acetoacetate in Human Plasma Using LC-MS.

Panse N, Halquist M, Gerk PM. Panse N, et al. Among authors: gerk pm. AAPS PharmSciTech. 2023 Sep 12;24(7):184. doi: 10.1208/s12249-023-02633-5. AAPS PharmSciTech. 2023. PMID: 37700072

3

Lack of interaction between tauroursodeoxycholate and ATP-binding cassette transporter isoform G2 (ABCG2).

Vaidya SS, Gerk PM. Vaidya SS, et al. Among authors: gerk pm. Mol Pharm. 2006 May-Jun;3(3):303-6. doi: 10.1021/mp0600079. Mol Pharm. 2006. PMID: 16749862

4

Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments.

Vaidya SS, Walsh SW, Gerk PM. Vaidya SS, et al. Among authors: gerk pm. Mol Pharm. 2009 Nov-Dec;6(6):1689-702. doi: 10.1021/mp900019z. Mol Pharm. 2009. PMID: 19397308

5

Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges.

Verenich S, Gerk PM. Verenich S, et al. Among authors: gerk pm. Mol Pharm. 2010 Dec 6;7(6):2030-9. doi: 10.1021/mp100190f. Epub 2010 Oct 21. Mol Pharm. 2010. PMID: 20831190 Free PMC article. Review.

6

Receptor-mediated endocytosis across human placenta: emphasis on megalin.

Akour AA, Kennedy MJ, Gerk P. Akour AA, et al. Mol Pharm. 2013 Apr 1;10(4):1269-78. doi: 10.1021/mp300609c. Epub 2013 Mar 21. Mol Pharm. 2013. PMID: 23438198 Review.

7

Inhibition of glucuronidation and oxidative metabolism of buprenorphine using GRAS compounds or dietary constituents/supplements: in vitro proof of concept.

Maharao NV, Joshi AA, Gerk PM. Maharao NV, et al. Among authors: gerk pm. Biopharm Drug Dispos. 2017 Mar;38(2):139-154. doi: 10.1002/bdd.2050. Epub 2017 Jan 24. Biopharm Drug Dispos. 2017. PMID: 27925249

8

Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.

Mitra P, Venitz J, Yuan Y, Zhang Y, Gerk PM. Mitra P, et al. Among authors: gerk pm. Drug Metab Dispos. 2011 Sep;39(9):1589-96. doi: 10.1124/dmd.111.038588. Epub 2011 Jun 17. Drug Metab Dispos. 2011. PMID: 21685245 Free PMC article.

9

Improving the oral bioavailability of buprenorphine: an in-vivo proof of concept.

Joshi A, Halquist M, Konsoula Z, Liu Y, Jones JP 3rd, Heidbreder C, Gerk PM. Joshi A, et al. Among authors: gerk pm. J Pharm Pharmacol. 2017 Jan;69(1):23-31. doi: 10.1111/jphp.12652. Epub 2016 Oct 26. J Pharm Pharmacol. 2017. PMID: 27781278

10

Effects of generally recognized as safe (GRAS) and dietary compounds on phenylephrine metabolism in LS180 human intestinal cells.

Zhang Z, Gerk PM. Zhang Z, et al. Among authors: gerk pm. Biopharm Drug Dispos. 2018 Nov;39(9):443-447. doi: 10.1002/bdd.2162. Epub 2018 Nov 18. Biopharm Drug Dispos. 2018. PMID: 30368855

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters